Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK - HENRIK BANG FREDERIKSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.4% 1.2% 2.0% 1.3% 1.8% 2.0% 7.3% 7.3%   Credit score (0-100)   65 83 68 78 70 68 33 33   Credit rating   BBB A A A A A BBB BBB   Credit limit (kDKK)   0.0 66.1 0.2 29.0 1.0 0.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   957 1,841 842 1,263 1,065 1,177 0.0 0.0   EBITDA   407 1,250 392 694 485 486 0.0 0.0   EBIT   157 1,009 151 502 240 241 0.0 0.0   Pre-tax profit (PTP)   95.3 898.8 98.1 461.9 203.0 184.7 0.0 0.0   Net earnings   65.8 696.6 95.1 427.6 129.8 91.6 0.0 0.0   Pre-tax profit without non-rec. items   95.3 899 98.1 462 203 185 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   825 689 563 943 813 684 0.0 0.0   Shareholders equity total   1,249 1,842 1,842 2,166 2,181 2,155 1,908 1,908   Interest-bearing liabilities   1,019 1,467 1,323 1,473 1,283 963 0.0 0.0   Balance sheet total (assets)   2,614 3,934 3,576 3,970 3,747 3,447 1,908 1,908   Net Debt   1,019 1,467 1,323 1,473 1,283 963 -1,057 -1,057     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   957 1,841 842 1,263 1,065 1,177 0.0 0.0   Gross profit growth   -18.9% 92.4% -54.2% 49.9% -15.7% 10.5% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,614 3,934 3,576 3,970 3,747 3,447 1,908 1,908   Balance sheet change%   3.2% 50.5% -9.1% 11.0% -5.6% -8.0% -44.6% 0.0%   Added value   406.9 1,250.0 392.3 693.6 432.1 486.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -139 -521 -482 74 -489 -489 -684 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.4% 54.8% 17.9% 39.7% 22.6% 20.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.1% 30.8% 5.1% 14.4% 7.5% 7.7% 0.0% 0.0%   ROI %   6.4% 33.1% 5.5% 15.2% 7.9% 8.1% 0.0% 0.0%   ROE %   5.2% 45.1% 5.2% 21.3% 6.0% 4.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   47.8% 46.8% 51.5% 54.6% 58.2% 62.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   250.4% 117.3% 337.2% 212.4% 264.5% 198.1% 0.0% 0.0%   Gearing %   81.6% 79.6% 71.8% 68.0% 58.8% 44.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.6% 8.9% 6.6% 5.7% 6.3% 8.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 1.3 0.5 0.5 0.4 0.3 0.0 0.0   Current Ratio   0.3 1.3 0.5 0.5 0.4 0.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -56.3 125.0 -575.3 -661.6 -648.4 -654.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   407 1,250 392 694 432 486 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   407 1,250 392 694 485 486 0 0   EBIT / employee   157 1,009 151 502 240 241 0 0   Net earnings / employee   66 697 95 428 130 92 0 0